Publications by authors named "Toshima Parris"

Claim this Profile
C
Correction: Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence.
Anikó Kovács, Leif Klint, Barbro Linderholm, Toshima Z Parris

Breast Cancer Res Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact on prognosis and treatment response.
Nanfizat A Alamukii, Anikó Kovács, Sukanya Raghavan, Josefin Ilio, Per Karlsson, Toshima Z Parris

NPJ Breast Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel gene rearrangement leads to altered expression of Hornerin in sensitive and chemoresistant ovarian cancer.
Ghassan M Saed, Harvey Sharma, Jenna Dabaja, Asad Nawaz, Ayesha Alvero, Toshima Z Parris

Transl Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worse survival despite indolent features for triple-negative invasive lobular carcinoma: a Swedish nationwide registry-based study.
Jenny Nyqvist-Streng, Chaido Chamalidou, Anikó Kovacs, Toshima Z Parris

Breast Cancer Res Treat· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence.
Anikó Kovács, Leif Klint, Barbro Linderholm, Toshima Z Parris

Breast Cancer Res Treat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer.
Ella Ittner, Hugo Swenson, Lucas Werner, Elisabeth Werner Rönnerman, Constantina Mateoiu, Toshima Z Parris

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics.
Lucas Werner, Ella Ittner, Hugo Swenson, Elisabeth Werner Rönnerman, Claudia Mateoiu, Toshima Z Parris

Mol Ther Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early proteomic response in thyroid gland after 131I administration in female Balb/c mice.
Nils Rudqvist, Johan Spetz, Emil Schüler, Toshima Z Parris, Britta Langen

Radiat Prot Dosimetry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age and comorbidity in relation to treatment and survival outcomes in triple-negative breast cancer: A Swedish nationwide registry-based study.
Jenny Nyqvist-Streng, Josef Somi, Jari Martikainen, Maxim Olsson, Khalil Helou, Toshima Z Parris

J Geriatr Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer: A UK Biobank study.
Lisa Tuomi, Toshima Z Parris, Araz Rawshani, Erik Andersson, Alina Orozco

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma.
Hugo Swenson, Ella Ittner, Lucas Werner, Elisabeth Werner Rönnerman, Claudia Mateoiu, Toshima Z Parris

J Ovarian Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study.
Jenny Nyqvist-Streng, Mikael Helou, Khalil Helou, Chaido Chamalidou, Anikó Kovács, Toshima Z Parris

Breast Cancer Res Treat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes in hormone receptor-negative breast cancer among BRCA carriers versus noncarriers in western Sweden.
Anna-Karin Tzikas, Erik Holmberg, Toshima Z Parris, Anikó Kovács, Lovisa Lovmar

Acta Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuated titin protein expression is associated with advanced stages of ovarian cancer.
Harvey Sharma, Jaskaran Aujla, Asad Nawaz, Thabet Khasawneh, Ayesha Alvero, Toshima Z Parris

Mol Ther Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer.
Ghassan M Saed, Nicole M Fletcher, Harvey Sharma, Axel Stenmark Tullberg, Ella Ittner, Toshima Z Parris

Mol Ther Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancers.
Peter Larsson, Maxim Olsson, Sithumini Sarathchandra, Anna Fäldt Beding, Eva Forssell-Aronsson, Toshima Z Parris

Sci Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties.
Peter Larsson, Maria Cristina De Rosa, Benedetta Righino, Maxim Olsson, Bogdan Iulius Florea, Toshima Z Parris

Sci Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Recombinant α-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to Lu-Octreotate.
Charlotte Ytterbrink, Emman Shubbar, Toshima Z Parris, Britta Langen, Malin Druid

Int J Mol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital RNA sequencing using unique molecular identifiers enables ultrasensitive RNA mutation analysis.
Manuel Luna Santamaría, Daniel Andersson, Toshima Z Parris, Khalil Helou, Tobias Österlund

Commun Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer.
Peter Larsson, Daniella Pettersson, Maxim Olsson, Sithumini Sarathchandra, Alexandra Abramsson, Toshima Z Parris

Cell Death Discov· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes .
Maxim Olsson, Peter Larsson, Junko Johansson, Vasu R Sah, Toshima Z Parris

Front Cell Dev Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases.
Slavica Janeva, Toshima Z Parris, Ellen Krabbe, Marie Sundquist, Per Karlsson

Clin Exp Metastasis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Cell Viability Assays for Drug Sensitivity Screens.
Peter Larsson, Toshima Z Parris

Methods Mol Biol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer.
Slavica Janeva, Ellen Krabbe, Toshima Z Parris, Salmir Nasic, Marie Sundquist

Breast Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinoma.
Elisabeth Werner Rönnerman, Daniella Pettersson, Szilárd Nemes, Pernilla Dahm-Kähler, Anikó Kovács, Toshima Z Parris

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis